Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2010
10/27/2010CN101088521B Astragalus medicine prepn and its prepn process
10/27/2010CN101044162B GLP-1 analog fusion protein formulations
10/26/2010US7820847 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
10/26/2010US7820837 Condensed ring compound
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820804 increases the effect on Sodium-dependent glucose cotransporters (SGLT); for lowering blood glucose; treatment of type 1 and type 2 diabetes; N-(2-Carbamoylethyl)-4-[1-(2-cyano-ethyl)-5-hydroxy-3-isopropyl-1H-pyrazol-4-ylmethyl]benzamide
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820197 Using bisphosphonic acid compound; mixture with solubilizer; permeability through skin
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2598725C Fused aromatic compounds having anti-diabetic activity
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2422708C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/26/2010CA2396956C Polypharmacophoric agents
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120797A2 Methods of reduction of interpatient variability
10/21/2010WO2010120736A1 High fiber nutritional emulsions for blood glucose control
10/21/2010WO2010120508A2 Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders
10/21/2010WO2010120237A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010WO2010120029A1 Composition comprising the extract of anemarrhena asphodeloides bunge or the compounds isolated from the same for preventing and treating lipid metabolism disorder
10/21/2010WO2010119990A1 Pharmaceutical compositions
10/21/2010WO2010119984A1 3-aryl or heteroaryl-substituted indole derivative
10/21/2010WO2010119881A1 Indoline compound
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119803A1 Lipid metabolism-improving agent
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010119674A1 Pharmaceutical composition for ameliorating and/or preventing leptin resistance, and use thereof
10/21/2010WO2010119161A2 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010118474A1 Compounds affecting glycemic index
10/21/2010WO2010092163A3 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
10/21/2010WO2010091892A3 Alkylamido compounds and uses thereof
10/21/2010WO2010087577A3 Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases
10/21/2010WO2010076813A4 Thienopyridines as pharmacologically active agents
10/21/2010WO2010072209A3 Food supplements based on pantothenic acid
10/21/2010WO2010071321A3 ORAL FORMULATIONS CONTAINING METFORMIN AND α-GLYCOSIDASE INHIBITOR, AND PREPARATION METHOD THEREOF
10/21/2010WO2010065815A3 Mini-hepcidin peptides and methods of using thereof
10/21/2010WO2010048358A3 Ethoxyphenylmethyl inhibitors of sglt2
10/21/2010US20100267936 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
10/21/2010US20100267831 Amino Acid-Containing Composition for Preventing or Remedying Decrease in the Skeletal Muscle of Aged People
10/21/2010US20100267829 Pharmaceutical composition comprising low concentrations of environment pollutants
10/21/2010US20100267828 dha derivatives and their use as medicaments
10/21/2010US20100267819 Pharmaceutical composition for diabetic nephropathy and its preparation and application
10/21/2010US20100267802 Delivery method
10/21/2010US20100267798 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267784 Novel 4,5-dihydroisoxazoles with estrogenic activity
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267780 Bicyclic aryl and heteroaryl receptor modulators
10/21/2010US20100267778 Diphenyl ether compound, process for producing the same, and use
10/21/2010US20100267775 Oxadiazolidinedione compound
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267767 Nuclear receptor binding agents
10/21/2010US20100267765 Pharmaceutical Compositions and Methods for CCR5 Antagonists
10/21/2010US20100267764 8-Aza-Bicyclo[3.2.1]Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/21/2010US20100267761 7-Azaindole Derivatives as Selective 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
10/21/2010US20100267757 Aminothiazoles and their uses
10/21/2010US20100267752 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/21/2010US20100267748 HETEROCYCLIC COMPOUNDS USEFUL AS STEAROYL CoA DESATURASE INHIBITORS
10/21/2010US20100267743 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010US20100267738 Novel amide and amidine derivatives and uses thereof
10/21/2010US20100267734 N-[(3,5-dichlorophenyl)methyl]-2-(4-methyl-1-piperazinyl)-2-(1-naphthalenyl)ethanamide as ghrelin receptor modulator
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267720 Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267708 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267690 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267687 Phenylpyrazole derivatives
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100267681 Fat or oil composition
10/21/2010US20100267669 Heterocyclic cetp inhibitors
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267667 Telomerase activating compounds and methods of use thereof
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267658 Trehalulose-containing composition, its preparation and use
10/21/2010US20100267651 T cell antigen receptor peptides
10/21/2010US20100267635 Use of protease inhibitors and grf molecules in combination therapy
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267631 Apolipoprotein a-i mimics
10/21/2010US20100267630 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases
10/21/2010US20100267629 Enterostatin as Therapeutic Agent for Hypoglycemia
10/21/2010US20100267628 Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes
10/21/2010US20100267627 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
10/21/2010US20100267626 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267618 Methods for treating congestive heart failure
10/21/2010US20100267615 Methods for treatment and/or prevention of a disease associated with vascular leak
10/21/2010US20100267611 Treatment of metabolic disease
10/21/2010US20100266681 Fatty acid alcohols
10/21/2010US20100266670 Transdermally absorptive preparation
10/21/2010US20100266665 Fenugreek Flour for Incorporating Into Food Products
10/21/2010US20100266644 Methods and compositions for administration of iron
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 1298